1. Jasmer RM, Nahid P, Hopewell PC. Clinical practice: latent tuberculosis infection. N Engl J Med. 2002. 347:1860–1866.
2. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004. 4:761–776.
Article
3. Dheda K, Udwadia ZF, Huggett JF, Johnson MA, Rook GA. Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med. 2005. 11:195–202.
Article
4. Pai M. Alternatives to the tuberculin skin test: Interferon-gamma assays in the diagnosis of mycobacterium tuberculosis infection. Indian J Med Microbiol. 2005. 23:151–158.
Article
5. Kang YA, Lee HW, Yoon HI, Cho BL, Han SK, Yim JJ, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA. 2005. 293:2756–2761.
Article
6. McHugh TD, Pope CF, Ling CL, Patel S, Billington OJ, Gillespie SH, et al. Prospective evaluation of BDProbeTec strand displacement amplification (SDA) system for diagnosis of tuberculosis in non-respiratory and respiratory samples. J Med Microbiol. 2004. 53:1215–1219.
Article
7. Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin Chest Med. 2005. 26:247–271.
Article
8. Lemaitre N, Armand S, Vachee A, Capilliez O, Dumoulin C, Courcol RJ. Comparison of the real-time PCR method and the Gen-Probe amplified
M. tuberculosis direct test for detection of
M. tuberculosis in pulmonary and nonpulmonary specimens. J Clin Microbiol. 2004. 42:4307–4309.
Article
9. Broccolo F, Scarpellini P, Locatelli G, Zingale A, Brambilla AM, Malnati MS, et al. Rapid diagnosis of mycobacterial infections and quantitation of
M. tuberculosis load by two realtime calibrated PCR assays. J Clin Microbiol. 2003. 41:4565–4572.
Article
10. Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: feasibility and applicability in the field. Eur Respir J. 2005. 26:339–350.
Article
11. Hazbon MH. Recent advances in molecular methods for early diagnosis of tuberculosis and drug-resistant tuberculosis. Biomedica. 2004. 24:Suppl. 149–162.
12. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in M. tuberculosis: a systematic review and meta-analysis. BMC Infect Dis. 2005. 5:62.
13. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in
M. tuberculosis complex isolates. J Clin Microbiol. 2005. 43:3699–3703.
Article
14. Gryadunov D, Mikhailovich V, Lapa S, Roudinskii N, Donnikov M, Mirzabekov A, et al. Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant
M. tuberculosis. Clin Microbiol Infect. 2005. 11:531–539.
Article
15. Ruiz M, Torres MJ, Llanos AC, Arroyo A, Palomares JC, Aznar J. Direct detection of rifampin- and isoniazidresistant
M. tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR. J Clin Microbiol. 2004. 42:1585–1589.
Article
16. Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL. Bacteriophage based assays for the rapid detection of rifampicin resistance in
M. tuberculosis: a meta-analysis. J Infect. 2005. 51:175–187.
Article
17. Hazbon MH, Guarin N, Ferro BE, Rodriguez AL, Labrada LA, Jacobs WR Jr, et al. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical
M. tuberculosis isolates. J Clin Microbiol. 2003. 41:4865–4869.
Article